VeonGen Therapeutics

Private

PlaneggHealthcare & Life Scienceshttps://veongen.com/

Last Round

Series A

Nov 28, 2019

Company Overview

VeonGen Therapeutics is a biotechnology company that develops innovative gene therapies for ophthalmic diseases and other genetic conditions using proprietary adeno-associated virus (AAV) technology platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapybiotechnologydrug discoverygenetic medicineAAVadeno-associated virusmRNA trans-splicingtherapeutic developmentbiotech pipelineCRISPRclinical-stage biotechbiopharmadrug developmentlicensing agreement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VeonGen Therapeutics Comps

Public and private peers based on sector, stage, and business model.

VeonGen Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

VeonGen Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Nov 28, 2019

View all Funding Rounds

VeonGen Therapeutics Investors

Notable investors and investment history

VeonGen Therapeutics investors
Investor	Rounds
HongShan	Series A
Ludwig-Maximilians-Universität München	Series A

View all Investors

VeonGen Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

VeonGen Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VeonGen Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersPlanegg

Employee Range10

Year Founded2017

Last FundingNov 28, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.